SCHEMBL30765796

SCHEMBL30765796

C[C@@H](N)c1ccc2c(c1)oc1ccccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
MAPT P10636 3/20 0.53
KDM4E B2RXH2 2/20 0.53
ALDH1A1 P00352 2/20 0.53
HPGD P15428 2/20 0.53
AHR P35869 2/20 0.50
BCHE P06276 4/20 0.48
ACHE P22303 4/20 0.48
NPC1 O15118 4/20 0.48
RAB9A P51151 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
GAA P10253 1/20 0.48
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
CYP2D6 P10635 1/20 0.43
TNKS O95271 1/20 0.42
PARP1 P09874 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30765633 0.89 MAPT (0.55) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL30765515 0.89 MAPT (0.55) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL30765533 0.89 MAPT (0.55) MEN1KMT2AMAPTKDM4EALDH1A1
Hydrochloric Acid SCHEMBL30765518 0.88 MAPT (0.53) MEN1KMT2AMAPTKDM4EALDH1A1
Hydrochloric Acid SCHEMBL31558469 0.88 MAPT (0.53) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL9916225 0.85 AHR (0.53) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL22924247 0.85 MEN1 (0.56) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL29887131 0.82 MEN1 (0.51) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL8610438 0.81 SMN1; SMN2 (0.48) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL7245461 0.81 MEN1 (0.53) MEN1KMT2AMAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568666-A1 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS Alexion Pharmaceuticals, Inc. (US) 2025-06-18 EP disclosed
CN-119768164-A Pharmaceutical compounds for treating complement-mediated disorders 阿雷克森制药公司 2025-04-04 CN disclosed
WO-2024035686-A1 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2024-02-15 WO disclosed